Hyper- and hypomagnesemia as an initial predictor of outcomes in septic pediatric patients in Egypt

Aya Osama Mohamed1

  • 1Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.

Acute and Critical Care
|February 20, 2025
PubMed

Insights

Serum magnesium levels in critically ill septic children can be a neglected electrolyte abnormality. While not a sole predictor, hypermagnesemia negatively impacts outcomes, warranting caution in magnesium administration.

Area of Science:

  • Pediatric critical care medicine
  • Clinical chemistry
  • Sepsis research

Background:

  • Critically ill septic children often experience electrolyte imbalances, including magnesium disturbances.
  • These magnesium abnormalities can be overlooked, potentially affecting patient outcomes.
  • This study investigated the relationship between initial serum magnesium levels and outcomes in pediatric sepsis.

Purpose of the Study:

  • To determine the correlation between serum magnesium levels on pediatric intensive care unit (PICU) admission and the outcomes of critically ill septic patients.
  • To identify predictors of mortality in pediatric sepsis.

Main Methods:

  • Prospective study involving 76 children with sepsis from May to November 2023.
  • Clinical and laboratory assessments, including initial magnesium levels, were performed.
  • Multivariate logistic regression and area under the curve (AUC) analysis were used to identify mortality predictors.

Main Results:

  • Median admission magnesium level was 2.0 mg/dl; levels were slightly higher in non-survivors.
  • Hypermagnesemia was associated with negative patient outcomes and lower C-reactive protein levels.
  • The pediatric Sequential Organ Failure Assessment score (cutoff 5.5) predicted mortality (AUC=0.717).

Conclusions:

  • Serum magnesium level alone is insufficient as an initial predictor of mortality.
  • Hypermagnesemia negatively impacts critically ill septic children.
  • Healthcare professionals should exercise caution when administering magnesium to these patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559